Skip to main content

Table 2 Comparison of general baseline data

From: High miRNA-378 expression has high diagnostic values for pulmonary tuberculosis and predicts adverse outcomes

factors

Control (N = 62)

Study (N = 126)

-

-

Active (N = 63)

Latent (N = 63)

Gender (female/male)

(37/25)

(37/26)

(42/21)

Age (≤ 45/ > 45)

(24/38)

(27/36)

(28/35)

Weight (≤ 60/ > 60)

(28/34)

(26/37)

(30/33)

Smoking history (yes/no)

(45/17)

(39/24)ab

(42/21)a

Drinking history (yes/no)

(35/27)

(51/12)

(49/14)

Expectoration (yes/no)

-

(58/5)ab

(47/16)a

Chest pain (yes/no)

-

(59/4)ab

(43/20)a

Low fever (yes/no)

-

(54/9)ab

(42/21)a

Hemoptysis (yes/no)

-

(57/6)ab

(14/49)a

M. tuberculosis culture positivity (yes/no)

-

(52/11)ab

-

Chronic bronchitis (yes/no)

(7/55)

(19/44)a

(13/50)

COPD (yes/no)

(5/57)

(14/49)a

(7/56)

Diabetes (yes/no)

(8/54)

(11/52)

(7/56)

Hypertension (yes/no)

(8/54)

(15/48)

(7/56)

Hyperlipidemia (yes/no)

(9/53)

(15/48)

(13/50)

  1. Note: The measurement data was expressed by the number of cases, and the comparison between the two groups was performed by independent t-test. M. tuberculosis Mycobacterium tuberculosis, COPD chronic obstructive pulmonary disease
  2. acompared with the control group, P < 0.05
  3. bcompared with the latent group, P < 0.05